The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, ...

Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...

Binance Coin (BNB) has gained by 1% today, July 25, to trade at $770. BNB’s rally took a breather after hitting a new high at $809 earlier this week. Even ...

Windtree Therapeutics secures $520M to pivot into a BNB-focused crypto treasury strategy, marking a bold move for corporate ...

Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, ...

Publicly traded companies are increasingly integrating cryptocurrencies other than Bitcoin (CRYPTO: BTC), into their treasuries, with significant investments announced in Ethereum (CRYPTO: ETH), Solan ...

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

Windtree Therapeutics secures $520M funding to expand its BNB Treasury, committing nearly $700M to digital asset reserves ...